Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial

The Women's Health Study trial previously reported no overall effect of low-dose aspirin (100 mg every other day) on invasive breast cancer over an average of 10 years of treatment. The present subgroup analyses further show no effects by tumour characteristics at diagnosis, suggesting that low...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, S M, Cook, N R, Manson, J E, Lee, I-M, Buring, J E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266841/
https://www.ncbi.nlm.nih.gov/pubmed/18268496
http://dx.doi.org/10.1038/sj.bjc.6604240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2266841/
https://www.ncbi.nlm.nih.gov/pubmed/18268496
http://dx.doi.org/10.1038/sj.bjc.6604240

Ejemplares similares